Core Laboratories N.V. (CLB) Wednesday reported first-quarter net income attributable to the company of $56.52 million or $1.22 per share, compared to $53.95 million or $1.13 per share in the comparable quarter last year.
Revenues for the quarter grew to $260.93 million from $234.19 million last year.
Analysts polled by Thomson Reuters expected the company to earn $1.16 per share on revenues of $247.22 million for the quarter. Analysts' estimates typically exclude special items.
Looking forward to the second quarter, Core expects earnings of $1.29 to $1.36 per share and revenues of $264 million to $269 million.
Analysts currently estimate earnings of $1.26 per share on revenues of $261.16 million for the quarter.
For the full-year 2013, the company increased its earnings to a range of $5.06 to $5.26 per share from its previous range of $4.96 to $5.22 per share. Revenues is expected to be in the range of $1.06 billion to $1.08 billion. Previously, the company expected revenues of $1.03 billion to $1.07 billion.
Analysts currently estimate earnings of $5.12 per share and revenues of $1.06 billion for the full-year 2013.
On 15 April 2013, the Board announced a quarterly cash dividend of $0.32 per share of common stock payable in the second quarter of 2013. The quarterly $0.32 per share cash dividend will be payable on 24 May 2013 for shareholders of record on 26 April 2013. Dutch withholding tax will be deducted from the dividend at a rate of 15%.
For comments and feedback: editorial@rttnews.com